Research and Markets: PharmaPoint: Migraine - Current and Future Players 2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/2kptnl/pharmapoint) has announced the addition of the "PharmaPoint: Migraine - Current and Future Players" report to their offering.

PharmaPoint: Migraine - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Migraine Market. The report identifies and analyses the key companies shaping and driving the global Migraine market. The report provides insight into the competitive Migraine landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by Our team of industry experts.

Scope

  • Investigation of current and future market competition for Migraine
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Migraine sector through market impact analysis, future market scenario and company analysis

Key Topics Covered:

  1. Tables & Figures
  2. Introduction
  3. Market Outlook
  4. Current and Future Players
  • GlaxoSmithKline
  • AstraZeneca
  • Merck
  • Vernalis
  • Almirall
  • Pfizer
  • Zogenix
  • NuPathe
  • Allergan
  • RedHill Biopharma
  • OptiNose
  • CoLucid Pharmaceuticals
  • SUDA
  • Revance Therapeutics
  • NeurAxon

For more information visit http://www.researchandmarkets.com/research/2kptnl/pharmapoint

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System